CUSIP: 004890109 | NYSE | Healthcare · Biotechnology | Micro Cap | 123 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13G/ASands Capital Life Sciences Pulse Fund II, L.P. | 2,289,271 | 5.3% | New 5%+ stake | Jun 30, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 46,188 | $94.7K | 0.0% | Index | Low | Austin, TX | 2026-11-04 | |
| 22,573 | $43.1K | 0.0% | ETF | Medium | New York, NY | 2026-11-03 | |
| 10,678 | $21.9K | 0.0% | ETF | Low | Westborough, MA | 2026-10-28 | |
| 2,715 | $5.6K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 584 | $1.2K | 0.0% | Index | Very Low | St. Louis, MO | 2026-10-20 | |
| 500 | $1.0K | 0.0% | ETF | Very Low | Redwood City, CA | 2026-11-02 | |
| 75 | $154 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 | |
| 3 | $6 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 |